Skip to content

Accelerated iTBS in Smoking Cessation

Accelerated Intermittent Theta Burst Stimulation in Smoking Cessation: A Randomized Controlled Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05271175
Enrollment
104
Registered
2022-03-08
Start date
2019-04-19
Completion date
2020-09-07
Last updated
2022-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nicotine Dependence, Smoking Cessation

Brief summary

Cigarette smoking is one of the foremost causes of preventable disease and premature death. In 2014, 68% of adult smokers wanted to quit smoking and in 2017, 55.1% of adult smokers had made a quit attempt. However, only a small percentage of adult smokers (7,4%) achieved to quit smoking. Transcranial magnetic stimulation (TMS) is a novel, powerful, non-invasive brain stimulation therapy. This study used Theta Burst Stimulation (TBS), a newer form of rTMS protocol that can be delivered in a shorter duration compared to the standard rTMS protocol, while delivering a comparable number of pulses. It is a tolerable, powerful, and useful tool in non-invasive brain stimulation therapies. This double-blind randomized control trial evaluated the efficacy of 4 iTBS sessions per day during 5 consecutive days over the left DLPFC in smoking cessation. Moreover, it investigated whether the exposure to smoking-related cues during the rTMS treatment, compared to neutral cues impact cigarette craving.

Detailed description

Cigarette smoking is one of the foremost causes of preventable disease and premature death. In 2014, 68% of adult smokers wanted to quit smoking and in 2017, 55.1% of adult smokers had made a quit attempt. However, only a small percentage of adult smokers (7,4%) achieved to quit smoking. Behavioral and psychological interventions, pharmacological interventions as well as nicotine replacement therapy are some of the most used interventions for smoking cessation with medium to low success rates. Nonetheless, in recent years there has been growing interest in new, alternative, and effective treatments for smoking cessation. Transcranial magnetic stimulation (TMS) is a novel, powerful, non-invasive brain stimulation therapy. TMS non-invasively (transcranially) delivers magnetic pulses to a brain region, inducing electric a current that can depolarize neurons and induce action potentials. This study used Theta Burst Stimulation (TBS), a newer form of rTMS protocol that can be delivered in a shorter duration compared to the standard rTMS protocol, while delivering a comparable number of pulses. It is a tolerable, powerful, and useful tool in non-invasive brain stimulation therapies. This double-blind randomized control trial evaluated the efficacy of 4 iTBS sessions per day during 5 consecutive days over the left DLPFC in smoking cessation. Moreover, it investigated whether the exposure to smoking-related cues during the rTMS treatment, compared to neutral cues impact cigarette craving. The investigators hypothesized that twenty sessions of accelerated theta burst simulation over the left DLPFC while exposed to smoking-related cues, would reduce cigarette consumption and cigarette cravings, accompanied by reduced stress and motivation to quit smoking, compared to both active and sham stimulation with neutral-cues. A total of 104 cigarettes smokers, who wanted to quit smoking, were enrolled and were randomly divided into the three experimental groups: the first group received active aiTBS stimulation while watching neutral videos, the second group received active aiTBS stimulation while watching smoking-related videos and the last group received sham stimulation while watching smoking-related videos. Primary and secondary measurements were performed at the baseline, during the treatment period, at one week, one month and six months post rTMS treatment.

Interventions

An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.

An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true double blinded clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.

Sponsors

Cyprus rTMS Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

1. aged 18-70 2. native or fluent Greek speaker.

Exclusion criteria

1. mental objects or implants in the brain, skull or near head (e.g., pacemakers, metal plates) 2. past or current of diagnosis of neurological or psychiatric disorder 3. use of psychiatric medication 4. past or current drug or alcohol abuse, other than nicotine 5. use of IQOS (I Quit Original Smoking) or electronic cigarettes (e-cigarettes).

Design outcomes

Primary

MeasureTime frameDescription
Carbon Monoxide (CO)- Evaluated Nicotine ConsumptionBaselineCO level was measured using the piCO Smokerlyzer breath carbon monoxide meter device prior to the first rTMS session.
Momentary CravingBaselineThe Visual Analogue Scale (VAS) is a psychometric measurement instrument that measures symptom severity on a continuous scale. The VAS can be quickly and repeatedly administered between tasks and it has been used extensively in smoking research with TMS. We used the VAS to assess smoking craving by asking participants to respond to the question How much do you want to smoke right now?, on a scale from 0 no craving to 100 most craving ever experienced by choosing a response on a visual scale given in front of them on a tablet.
General CravingBaselineTobacco Craving Questionnaire-Short Form (TCQ-SF) is a self-report measure that assesses tobacco craving in four dimensions. Each factor scale contains three items. TCQ-SF items were rated on a Likert scale of 1 (strongly disagree) to 7 (strongly agree). Total scores vary from 12 to 84, by summing the 12 items and the scores for each factor scale vary from 3 to 21 by summing the three items in each factor scale. A high score indicates high tobacco craving.
Self-reported Nicotine ConsumptionBaselineΤhe number of cigarettes participants usually smoke before the treatment.
Nicotine DependenceBaselineFagerström test for Nicotine Dependence (FTND) is a short, self-report measure that assesses nicotine dependence. It contains six questions, and the total score is calculated as a sum of these six questions. The scores vary from 0 to 10, with lower scores indicating lower dependence on nicotine.

Secondary

MeasureTime frameDescription
Motivation to Quit SmokingBaselineParticipants were asked to estimate how motivated they were to quit smoking from 0% to 100%. Τhe possible answers were: 0%, 25%, 50%, 75% and 100%. Higher values reflect greater motivation to quit smoking.
Perceived StressBaselinePerceived Stress Scale-4 (PSS-4) is a self-report measure that is used to assess psychological stress. PSS-4 items were rated on a Likert scale, ranging from 0 to 4, with those on the positive subscale scored in reverse and the total score was calculated as a sum of these items. The scores vary from 0-16, with a higher score indicating higher perceived stress.

Countries

Cyprus

Participant flow

Participants by arm

ArmCount
Active TMS & Neutral Videos
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
29
Active TMS & Smoking Videos
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
30
Sham TMS & Smoking Videos
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true double blinded clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
30
Total89

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
One Month Follow upLost to Follow-up1279
One Week Follow upLost to Follow-up1075
Six Months Follow upLost to Follow-up822

Baseline characteristics

CharacteristicActive TMS & Smoking VideosActive TMS & Neutral VideosSham TMS & Smoking VideosTotal
Age, Continuous42.93 years
STANDARD_DEVIATION 14.42
46.52 years
STANDARD_DEVIATION 13.05
47.43 years
STANDARD_DEVIATION 12.72
45.62 years
STANDARD_DEVIATION 13.42
Cigarettes per day26.83 cigarettes/day
STANDARD_DEVIATION 12.86
27.55 cigarettes/day
STANDARD_DEVIATION 15.37
30.00 cigarettes/day
STANDARD_DEVIATION 13.38
28.13 cigarettes/day
STANDARD_DEVIATION 13.8
Education14.43 years
STANDARD_DEVIATION 3.77
14.07 years
STANDARD_DEVIATION 3.95
13.60 years
STANDARD_DEVIATION 3.27
14.03 years
STANDARD_DEVIATION 3.65
How many times quitted1.00 quit attempts
STANDARD_DEVIATION 1.11
0.90 quit attempts
STANDARD_DEVIATION 0.77
1.20 quit attempts
STANDARD_DEVIATION 1.56
1.03 quit attempts
STANDARD_DEVIATION 1.19
If ever quitted
No
10 Participants9 Participants11 Participants30 Participants
If ever quitted
Yes
20 Participants20 Participants19 Participants59 Participants
Occupation
Private employee
19 Participants13 Participants22 Participants54 Participants
Occupation
Public employee
4 Participants7 Participants1 Participants12 Participants
Occupation
Retired
4 Participants2 Participants3 Participants9 Participants
Occupation
Self-employed / freelancer
1 Participants5 Participants4 Participants10 Participants
Occupation
Student
1 Participants0 Participants0 Participants1 Participants
Occupation
Unemployed
1 Participants2 Participants0 Participants3 Participants
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
10 Participants7 Participants12 Participants29 Participants
Sex: Female, Male
Male
20 Participants22 Participants18 Participants60 Participants
Types of cigarettes
Cigarillos
0 Participants1 Participants0 Participants1 Participants
Types of cigarettes
Hand-rolled
5 Participants10 Participants5 Participants20 Participants
Types of cigarettes
Mixed
0 Participants2 Participants1 Participants3 Participants
Types of cigarettes
Normal
25 Participants16 Participants24 Participants65 Participants
Years of smoking23.13 years
STANDARD_DEVIATION 13.58
23.18 years
STANDARD_DEVIATION 9.82
28.73 years
STANDARD_DEVIATION 12.21
25.06 years
STANDARD_DEVIATION 12.17

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 290 / 300 / 30
other
Total, other adverse events
11 / 295 / 307 / 30
serious
Total, serious adverse events
0 / 290 / 300 / 30

Outcome results

Primary

Carbon Monoxide (CO)- Evaluated Nicotine Consumption

The average of the four CO-levels, measured before each of the four sessions on Day 1.

Time frame: Day 1

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosCarbon Monoxide (CO)- Evaluated Nicotine Consumption19.09 ppmStandard Error 12.14
Active TMS & Smoking VideosCarbon Monoxide (CO)- Evaluated Nicotine Consumption14.83 ppmStandard Error 8.47
Sham TMS & Smoking VideosCarbon Monoxide (CO)- Evaluated Nicotine Consumption17.77 ppmStandard Error 7.88
Primary

Carbon Monoxide (CO)- Evaluated Nicotine Consumption

CO level was measured using the piCO Smokerlyzer breath carbon monoxide meter device prior to the first rTMS session.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosCarbon Monoxide (CO)- Evaluated Nicotine Consumption23.64 ppmStandard Deviation 14.68
Active TMS & Smoking VideosCarbon Monoxide (CO)- Evaluated Nicotine Consumption17.24 ppmStandard Deviation 10.17
Sham TMS & Smoking VideosCarbon Monoxide (CO)- Evaluated Nicotine Consumption21.13 ppmStandard Deviation 9.63
Primary

Carbon Monoxide (CO)- Evaluated Nicotine Consumption

The average of the four CO-levels, measured before each of the four sessions on Day 5.

Time frame: Day 5

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosCarbon Monoxide (CO)- Evaluated Nicotine Consumption8.98 ppmStandard Deviation 9.68
Active TMS & Smoking VideosCarbon Monoxide (CO)- Evaluated Nicotine Consumption8.03 ppmStandard Deviation 7.27
Sham TMS & Smoking VideosCarbon Monoxide (CO)- Evaluated Nicotine Consumption8.18 ppmStandard Deviation 7.02
Primary

Carbon Monoxide (CO)- Evaluated Nicotine Consumption

The average of the four CO-levels, measured before each of the four sessions on Day 4.

Time frame: Day 4

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosCarbon Monoxide (CO)- Evaluated Nicotine Consumption8.35 ppmStandard Deviation 8.44
Active TMS & Smoking VideosCarbon Monoxide (CO)- Evaluated Nicotine Consumption8.58 ppmStandard Deviation 6.65
Sham TMS & Smoking VideosCarbon Monoxide (CO)- Evaluated Nicotine Consumption8.89 ppmStandard Deviation 6.96
Primary

Carbon Monoxide (CO)- Evaluated Nicotine Consumption

The average of the four CO-levels, measured before each of the four sessions on Day 3.

Time frame: Day 3

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosCarbon Monoxide (CO)- Evaluated Nicotine Consumption9.98 ppmStandard Deviation 10.15
Active TMS & Smoking VideosCarbon Monoxide (CO)- Evaluated Nicotine Consumption9.61 ppmStandard Deviation 6.63
Sham TMS & Smoking VideosCarbon Monoxide (CO)- Evaluated Nicotine Consumption8.85 ppmStandard Deviation 6.58
Primary

Carbon Monoxide (CO)- Evaluated Nicotine Consumption

The average of the four CO-levels, measured before each of the four sessions on Day 2.

Time frame: Day 2

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosCarbon Monoxide (CO)- Evaluated Nicotine Consumption11.09 ppmStandard Deviation 9.69
Active TMS & Smoking VideosCarbon Monoxide (CO)- Evaluated Nicotine Consumption9.94 ppmStandard Deviation 8.17
Sham TMS & Smoking VideosCarbon Monoxide (CO)- Evaluated Nicotine Consumption11.03 ppmStandard Deviation 7.5
Primary

General Craving

Tobacco Craving Questionnaire-Short Form (TCQ-SF) is a self-report measure that assesses tobacco craving in four dimensions. Each factor scale contains three items. TCQ-SF items were rated on a Likert scale of 1 (strongly disagree) to 7 (strongly agree). Total scores vary from 12 to 84, by summing the 12 items and the scores for each factor scale vary from 3 to 21 by summing the three items in each factor scale. A high score indicates high tobacco craving.

Time frame: 1 month follow up

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosGeneral Craving37.06 Total scoreStandard Deviation 17.94
Active TMS & Smoking VideosGeneral Craving30.61 Total scoreStandard Deviation 19.63
Sham TMS & Smoking VideosGeneral Craving35.24 Total scoreStandard Deviation 20.63
Primary

General Craving

Tobacco Craving Questionnaire-Short Form (TCQ-SF) is a self-report measure that assesses tobacco craving in four dimensions. Each factor scale contains three items. TCQ-SF items were rated on a Likert scale of 1 (strongly disagree) to 7 (strongly agree). Total scores vary from 12 to 84, by summing the 12 items and the scores for each factor scale vary from 3 to 21 by summing the three items in each factor scale. A high score indicates high tobacco craving.

Time frame: 6 months follow up

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosGeneral Craving51.52 Total scoreStandard Deviation 19.5
Active TMS & Smoking VideosGeneral Craving38.32 Total scoreStandard Deviation 18.22
Sham TMS & Smoking VideosGeneral Craving44.68 Total scoreStandard Deviation 22.34
Primary

General Craving

Tobacco Craving Questionnaire-Short Form (TCQ-SF) is a self-report measure that assesses tobacco craving in four dimensions. Each factor scale contains three items. TCQ-SF items were rated on a Likert scale of 1 (strongly disagree) to 7 (strongly agree). Total scores vary from 12 to 84, by summing the 12 items and the scores for each factor scale vary from 3 to 21 by summing the three items in each factor scale. A high score indicates high tobacco craving.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosGeneral Craving45.38 Total scoreStandard Deviation 17.95
Active TMS & Smoking VideosGeneral Craving52.03 Total scoreStandard Deviation 16.2
Sham TMS & Smoking VideosGeneral Craving43.83 Total scoreStandard Deviation 17.25
Primary

General Craving

Tobacco Craving Questionnaire-Short Form (TCQ-SF) is a self-report measure that assesses tobacco craving in four dimensions. Each factor scale contains three items. TCQ-SF items were rated on a Likert scale of 1 (strongly disagree) to 7 (strongly agree). Total scores vary from 12 to 84, by summing the 12 items and the scores for each factor scale vary from 3 to 21 by summing the three items in each factor scale. A high score indicates high tobacco craving.

Time frame: End of the treatment (On the fifth day, after completing 20 TMS sessions)

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosGeneral Craving30.93 Total scoreStandard Deviation 17.05
Active TMS & Smoking VideosGeneral Craving31.97 Total scoreStandard Deviation 14.61
Sham TMS & Smoking VideosGeneral Craving28.63 Total scoreStandard Deviation 13.1
Primary

General Craving

Tobacco Craving Questionnaire-Short Form (TCQ-SF) is a self-report measure that assesses tobacco craving in four dimensions. Each factor scale contains three items. TCQ-SF items were rated on a Likert scale of 1 (strongly disagree) to 7 (strongly agree). Total scores vary from 12 to 84, by summing the 12 items and the scores for each factor scale vary from 3 to 21 by summing the three items in each factor scale. A high score indicates high tobacco craving.

Time frame: 1 week follow up

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosGeneral Craving29.84 Total scoreStandard Deviation 14.18
Active TMS & Smoking VideosGeneral Craving32.17 Total scoreStandard Deviation 21.57
Sham TMS & Smoking VideosGeneral Craving27.28 Total scoreStandard Deviation 14.82
Primary

Momentary Craving

The Visual Analogue Scale (VAS) is a psychometric measurement instrument that measures symptom severity on a continuous scale. The VAS can be quickly and repeatedly administered between tasks and it has been used extensively in smoking research with TMS. We used the VAS to assess smoking craving by asking participants to respond to the question How much do you want to smoke right now?, on a scale from 0 no craving to 100 most craving ever experienced by choosing a response on a visual scale given in front of them on a tablet. The average of the eight VAS scores, measured prior and post each of the four sessions on Day 4.

Time frame: Day 4

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosMomentary Craving9.16 score on a scaleStandard Deviation 13.12
Active TMS & Smoking VideosMomentary Craving20.14 score on a scaleStandard Deviation 18.41
Sham TMS & Smoking VideosMomentary Craving14.44 score on a scaleStandard Deviation 19.18
Primary

Momentary Craving

The Visual Analogue Scale (VAS) is a psychometric measurement instrument that measures symptom severity on a continuous scale. The VAS can be quickly and repeatedly administered between tasks and it has been used extensively in smoking research with TMS. We used the VAS to assess smoking craving by asking participants to respond to the question How much do you want to smoke right now?, on a scale from 0 no craving to 100 most craving ever experienced by choosing a response on a visual scale given in front of them on a tablet. The average of the eight VAS scores, measured prior and post each of the four sessions on Day 5.

Time frame: Day 5

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosMomentary Craving10.57 score on a scaleStandard Deviation 15.74
Active TMS & Smoking VideosMomentary Craving16.08 score on a scaleStandard Deviation 16.14
Sham TMS & Smoking VideosMomentary Craving10.46 score on a scaleStandard Deviation 13.13
Primary

Momentary Craving

The Visual Analogue Scale (VAS) is a psychometric measurement instrument that measures symptom severity on a continuous scale. The VAS can be quickly and repeatedly administered between tasks and it has been used extensively in smoking research with TMS. We used the VAS to assess smoking craving by asking participants to respond to the question How much do you want to smoke right now?, on a scale from 0 no craving to 100 most craving ever experienced by choosing a response on a visual scale given in front of them on a tablet.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosMomentary Craving24.21 score on a scaleStandard Deviation 30.64
Active TMS & Smoking VideosMomentary Craving30.87 score on a scaleStandard Deviation 28.63
Sham TMS & Smoking VideosMomentary Craving25.70 score on a scaleStandard Deviation 30.42
Primary

Momentary Craving

The Visual Analogue Scale (VAS) is a psychometric measurement instrument that measures symptom severity on a continuous scale. The VAS can be quickly and repeatedly administered between tasks and it has been used extensively in smoking research with TMS. We used the VAS to assess smoking craving by asking participants to respond to the question How much do you want to smoke right now?, on a scale from 0 no craving to 100 most craving ever experienced by choosing a response on a visual scale given in front of them on a tablet. The average of the eight VAS scores, measured prior and post each of the four sessions on Day 1.

Time frame: Day 1

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosMomentary Craving24.55 score on a scaleStandard Deviation 20.66
Active TMS & Smoking VideosMomentary Craving33.13 score on a scaleStandard Deviation 22.12
Sham TMS & Smoking VideosMomentary Craving29.03 score on a scaleStandard Deviation 28.59
Primary

Momentary Craving

The Visual Analogue Scale (VAS) is a psychometric measurement instrument that measures symptom severity on a continuous scale. The VAS can be quickly and repeatedly administered between tasks and it has been used extensively in smoking research with TMS. We used the VAS to assess smoking craving by asking participants to respond to the question How much do you want to smoke right now?, on a scale from 0 no craving to 100 most craving ever experienced by choosing a response on a visual scale given in front of them on a tablet. The average of the eight VAS scores, measured prior and post each of the four sessions on Day 2.

Time frame: Day 2

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosMomentary Craving15.62 score on a scaleStandard Deviation 16.69
Active TMS & Smoking VideosMomentary Craving23.54 score on a scaleStandard Deviation 18.88
Sham TMS & Smoking VideosMomentary Craving21.87 score on a scaleStandard Deviation 24.12
Primary

Momentary Craving

The Visual Analogue Scale (VAS) is a psychometric measurement instrument that measures symptom severity on a continuous scale. The VAS can be quickly and repeatedly administered between tasks and it has been used extensively in smoking research with TMS. We used the VAS to assess smoking craving by asking participants to respond to the question How much do you want to smoke right now?, on a scale from 0 no craving to 100 most craving ever experienced by choosing a response on a visual scale given in front of them on a tablet. The average of the eight VAS scores, measured prior and post each of the four sessions on Day 3.

Time frame: Day 3

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosMomentary Craving12.45 score on a scaleStandard Deviation 15.33
Active TMS & Smoking VideosMomentary Craving22.32 score on a scaleStandard Deviation 19.87
Sham TMS & Smoking VideosMomentary Craving17.48 score on a scaleStandard Deviation 21.78
Primary

Nicotine Dependence

Fagerström test for Nicotine Dependence (FTND) is a short, self-report measure that assesses nicotine dependence. It contains six questions, and the total score is calculated as a sum of these six questions. The scores vary from 0 to 10, with lower scores indicating lower dependence on nicotine.

Time frame: 1 month follow up

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosNicotine Dependence3.35 score on a scaleStandard Deviation 1.97
Active TMS & Smoking VideosNicotine Dependence2.78 score on a scaleStandard Deviation 2.8
Sham TMS & Smoking VideosNicotine Dependence3.38 score on a scaleStandard Deviation 2.84
Primary

Nicotine Dependence

Fagerström test for Nicotine Dependence (FTND) is a short, self-report measure that assesses nicotine dependence. It contains six questions, and the total score is calculated as a sum of these six questions. The scores vary from 0 to 10, with lower scores indicating lower dependence on nicotine.

Time frame: 6 months follow up

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosNicotine Dependence3.71 score on a scaleStandard Deviation 2.43
Active TMS & Smoking VideosNicotine Dependence3.32 score on a scaleStandard Deviation 2.74
Sham TMS & Smoking VideosNicotine Dependence3.96 score on a scaleStandard Deviation 2.57
Primary

Nicotine Dependence

Fagerström test for Nicotine Dependence (FTND) is a short, self-report measure that assesses nicotine dependence. It contains six questions, and the total score is calculated as a sum of these six questions. The scores vary from 0 to 10, with lower scores indicating lower dependence on nicotine.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosNicotine Dependence5.86 score on a scaleStandard Deviation 2.26
Active TMS & Smoking VideosNicotine Dependence6.03 score on a scaleStandard Deviation 2.37
Sham TMS & Smoking VideosNicotine Dependence6.77 score on a scaleStandard Deviation 2.27
Primary

Nicotine Dependence

Fagerström test for Nicotine Dependence (FTND) is a short, self-report measure that assesses nicotine dependence. It contains six questions, and the total score is calculated as a sum of these six questions. The scores vary from 0 to 10, with lower scores indicating lower dependence on nicotine.

Time frame: End of the treatment (On the fifth day, after completing 20 TMS sessions)

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosNicotine Dependence2.31 score on a scaleStandard Deviation 2.62
Active TMS & Smoking VideosNicotine Dependence2.03 score on a scaleStandard Deviation 2.08
Sham TMS & Smoking VideosNicotine Dependence2.57 score on a scaleStandard Deviation 2.69
Primary

Nicotine Dependence

Fagerström test for Nicotine Dependence (FTND) is a short, self-report measure that assesses nicotine dependence. It contains six questions, and the total score is calculated as a sum of these six questions. The scores vary from 0 to 10, with lower scores indicating lower dependence on nicotine.

Time frame: 1 week follow up

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosNicotine Dependence1.79 score on a scaleStandard Deviation 1.55
Active TMS & Smoking VideosNicotine Dependence2.04 score on a scaleStandard Deviation 2.49
Sham TMS & Smoking VideosNicotine Dependence2.64 score on a scaleStandard Deviation 2.41
Primary

Self-reported Nicotine Consumption

Participants were required to record the number of cigarettes smoked after the completion of the 2nd day of treatment until before the first session on the 3rd day of treatment. Participants were asked not to smoke during the breaks of the 4 daily rTMS sessions

Time frame: After 2nd treatment day

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosSelf-reported Nicotine Consumption7.94 cigarettes/dayStandard Deviation 8.13
Active TMS & Smoking VideosSelf-reported Nicotine Consumption7.07 cigarettes/dayStandard Deviation 6.43
Sham TMS & Smoking VideosSelf-reported Nicotine Consumption9.38 cigarettes/dayStandard Deviation 7.9
Primary

Self-reported Nicotine Consumption

Τhe number of cigarettes participants usually smoke before the treatment.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosSelf-reported Nicotine Consumption27.55 cigarettes/dayStandard Error 15.37
Active TMS & Smoking VideosSelf-reported Nicotine Consumption26.83 cigarettes/dayStandard Error 12.86
Sham TMS & Smoking VideosSelf-reported Nicotine Consumption30.00 cigarettes/dayStandard Error 13.38
Primary

Self-reported Nicotine Consumption

Participants were required to record the number of cigarettes smoked after the completion of the 4th day of treatment until before the first session on the 5th day of treatment . Participants were asked not to smoke during the breaks of the 4 daily rTMS sessions

Time frame: After 4th treatment day

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosSelf-reported Nicotine Consumption5.27 cigarettes/dayStandard Deviation 7.51
Active TMS & Smoking VideosSelf-reported Nicotine Consumption4.67 cigarettes/dayStandard Deviation 6.5
Sham TMS & Smoking VideosSelf-reported Nicotine Consumption6.27 cigarettes/dayStandard Deviation 7.84
Primary

Self-reported Nicotine Consumption

Participants were required to record the number of cigarettes smoked after the completion of the 3rd day of treatment until before the first session on the 4th day of treatment. Participants were asked not to smoke during the breaks of the 4 daily rTMS sessions

Time frame: After 3rd treatment day

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosSelf-reported Nicotine Consumption5.92 cigarettes/dayStandard Deviation 6.68
Active TMS & Smoking VideosSelf-reported Nicotine Consumption7.79 cigarettes/dayStandard Deviation 8.61
Sham TMS & Smoking VideosSelf-reported Nicotine Consumption8.20 cigarettes/dayStandard Deviation 7.8
Primary

Self-reported Nicotine Consumption

Participants were required to record the number of cigarettes smoked after the completion of the 1st day of treatment until before the first session on the second day of treatment. Participants were asked not to smoke during the breaks of the 4 daily rTMS sessions

Time frame: After 1st treatment day

Population: Two participants from the Active TMS \& Neutral videos group and three participants from the Active TMS \& Smoking videos group were outliers and were therefore excluded from the analyses.

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosSelf-reported Nicotine Consumption8.72 cigarettes/dayStandard Deviation 8.97
Active TMS & Smoking VideosSelf-reported Nicotine Consumption8.67 cigarettes/dayStandard Deviation 8.56
Sham TMS & Smoking VideosSelf-reported Nicotine Consumption10.60 cigarettes/dayStandard Deviation 7.49
Secondary

Motivation to Quit Smoking

Participants were asked to estimate how motivated they were to quit smoking from 0% to 100%. Τhe possible answers were: 0%, 25%, 50%, 75% and 100%. Higher values reflect greater motivation to quit smoking.

Time frame: 6 months follow up

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosMotivation to Quit Smoking41.67 score on a scaleStandard Deviation 34.76
Active TMS & Smoking VideosMotivation to Quit Smoking67.86 score on a scaleStandard Deviation 32.53
Sham TMS & Smoking VideosMotivation to Quit Smoking52.68 score on a scaleStandard Deviation 34.92
Secondary

Motivation to Quit Smoking

Participants were asked to estimate how motivated they were to quit smoking from 0% to 100%. Τhe possible answers were: 0%, 25%, 50%, 75% and 100%. Higher values reflect greater motivation to quit smoking.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosMotivation to Quit Smoking77.78 score on a scaleStandard Deviation 21.18
Active TMS & Smoking VideosMotivation to Quit Smoking82.41 score on a scaleStandard Deviation 18.1
Sham TMS & Smoking VideosMotivation to Quit Smoking80.83 score on a scaleStandard Deviation 20.43
Secondary

Motivation to Quit Smoking

Participants were asked to estimate how motivated they were to quit smoking from 0% to 100%. Τhe possible answers were: 0%, 25%, 50%, 75% and 100%. Higher values reflect greater motivation to quit smoking.

Time frame: End of the treatment (On the fifth day, after completing 20 TMS sessions)

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosMotivation to Quit Smoking82.41 score on a scaleStandard Deviation 20.59
Active TMS & Smoking VideosMotivation to Quit Smoking84.26 score on a scaleStandard Deviation 19.79
Sham TMS & Smoking VideosMotivation to Quit Smoking80.83 score on a scaleStandard Deviation 23.38
Secondary

Motivation to Quit Smoking

Participants were asked to estimate how motivated they were to quit smoking from 0% to 100%. Τhe possible answers were: 0%, 25%, 50%, 75% and 100%. Higher values reflect greater motivation to quit smoking.

Time frame: 1 week follow up

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosMotivation to Quit Smoking72.37 score on a scaleStandard Deviation 23.41
Active TMS & Smoking VideosMotivation to Quit Smoking77.17 score on a scaleStandard Deviation 30.07
Sham TMS & Smoking VideosMotivation to Quit Smoking75.00 score on a scaleStandard Deviation 27.95
Secondary

Motivation to Quit Smoking

Participants were asked to estimate how motivated they were to quit smoking from 0% to 100%. Τhe possible answers were: 0%, 25%, 50%, 75% and 100%. Higher values reflect greater motivation to quit smoking.

Time frame: 1 month follow up

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosMotivation to Quit Smoking47.06 score on a scaleStandard Deviation 31.72
Active TMS & Smoking VideosMotivation to Quit Smoking70.65 score on a scaleStandard Deviation 37.43
Sham TMS & Smoking VideosMotivation to Quit Smoking52.38 score on a scaleStandard Deviation 38.65
Secondary

Perceived Stress

Perceived Stress Scale-4 (PSS-4) is a self-report measure that is used to assess psychological stress. PSS-4 items were rated on a Likert scale, ranging from 0 to 4, with those on the positive subscale scored in reverse and the total score was calculated as a sum of these items. The scores vary from 0-16, with a higher score indicating higher perceived stress.

Time frame: 1 month follow up

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosPerceived Stress4.06 score on a scaleStandard Deviation 2.66
Active TMS & Smoking VideosPerceived Stress5.57 score on a scaleStandard Deviation 2.13
Sham TMS & Smoking VideosPerceived Stress3.52 score on a scaleStandard Deviation 2.48
Secondary

Perceived Stress

Perceived Stress Scale-4 (PSS-4) is a self-report measure that is used to assess psychological stress. PSS-4 items were rated on a Likert scale, ranging from 0 to 4, with those on the positive subscale scored in reverse and the total score was calculated as a sum of these items. The scores vary from 0-16, with a higher score indicating higher perceived stress.

Time frame: 1 week follow up

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosPerceived Stress4.42 score on a scaleStandard Deviation 2.59
Active TMS & Smoking VideosPerceived Stress6.00 score on a scaleStandard Deviation 2.66
Sham TMS & Smoking VideosPerceived Stress4.76 score on a scaleStandard Deviation 2.35
Secondary

Perceived Stress

Perceived Stress Scale-4 (PSS-4) is a self-report measure that is used to assess psychological stress. PSS-4 items were rated on a Likert scale, ranging from 0 to 4, with those on the positive subscale scored in reverse and the total score was calculated as a sum of these items. The scores vary from 0-16, with a higher score indicating higher perceived stress.

Time frame: 6 months follow up

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosPerceived Stress4.67 score on a scaleStandard Deviation 1.88
Active TMS & Smoking VideosPerceived Stress5.75 score on a scaleStandard Deviation 2.05
Sham TMS & Smoking VideosPerceived Stress4.75 score on a scaleStandard Deviation 2.52
Secondary

Perceived Stress

Perceived Stress Scale-4 (PSS-4) is a self-report measure that is used to assess psychological stress. PSS-4 items were rated on a Likert scale, ranging from 0 to 4, with those on the positive subscale scored in reverse and the total score was calculated as a sum of these items. The scores vary from 0-16, with a higher score indicating higher perceived stress.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosPerceived Stress5.97 score on a scaleStandard Deviation 2.18
Active TMS & Smoking VideosPerceived Stress6.53 score on a scaleStandard Deviation 2.4
Sham TMS & Smoking VideosPerceived Stress5.60 score on a scaleStandard Deviation 1.98
Secondary

Perceived Stress

Perceived Stress Scale-4 (PSS-4) is a self-report measure that is used to assess psychological stress. PSS-4 items were rated on a Likert scale, ranging from 0 to 4, with those on the positive subscale scored in reverse and the total score was calculated as a sum of these items. The scores vary from 0-16, with a higher score indicating higher perceived stress.

Time frame: End of the treatment (On the fifth day, after completing 20 TMS sessions)

ArmMeasureValue (MEAN)Dispersion
Active TMS & Neutral VideosPerceived Stress5.21 score on a scaleStandard Deviation 2.47
Active TMS & Smoking VideosPerceived Stress5.90 score on a scaleStandard Deviation 2.34
Sham TMS & Smoking VideosPerceived Stress4.60 score on a scaleStandard Deviation 1.96

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026